# Verapamil

Drug · id `cardio:verapamil` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Verapamil hydrochloride

Browse, organ or system: Heart  
Browse, condition area: High blood pressure; Coronary and vascular disease; Heart rhythm problems  

## In plain language

Verapamil is a calcium channel blocker. The US label read is for verapamil hydrochloride tablets and lists three groups of uses: angina (angina at rest, including vasospastic and unstable angina, and chronic stable angina); arrhythmias (control of ventricular rate in chronic atrial flutter or atrial fibrillation, in association with digitalis, and prophylaxis of repetitive paroxysmal supraventricular tachycardia); and hypertension, to lower blood pressure. No brand-name tablet label for the immediate-release product was found in openFDA, so this page rests on a generic manufacturer's label. Extended-release products and the injection have their own labels, which were not read.

## Technical summary

RxNorm ingredient 11170; UNII V3888OEY5R. The label names the substance as verapamil hydrochloride, so UNII V3888OEY5R is the UNII of the salt form and is a broad match. MeSH descriptor D014700 is Verapamil. Class: Calcium Channel Blocker (FDA established pharmacologic class, RxClass). The label read is the verapamil hydrochloride tablets, Actavis Pharma, Inc. label, effective 2024-01-30 in openFDA (application ANDA070995). Other verapamil labels in openFDA, from other sponsors and repackagers, were not read. This page records label indications and the class only: no trial result and no dose is given.

## Claims, with the population each applies to

## Context: People for whom the US label of verapamil hydrochloride tablets lists an indication: angina, atrial flutter or fibrillation, supraventricular tachycardia, hypertension

Recipient: Recipient not specified; Population: Patients described in the indications section of the label. The label does not state an age range in the passages read.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)

### The US label of verapamil hydrochloride tablets, in the Actavis Pharma, Inc. version dated 2024-01-30 in openFDA, lists the medicine for angina (angina at rest, including vasospastic and unstable angina, and chronic stable angina); for arrhythmias (control of ventricular rate at rest and during stress, in association with digitalis, in patients with chronic atrial flutter or atrial fibrillation, and prophylaxis of repetitive paroxysmal supraventricular tachycardia); and for the treatment of hypertension, to lower blood pressure.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Recipient not specified; Population: Patients described in the indications section of the label. The label does not state an age range in the passages read.; Care setting: Prescription medicine, as described in the US label; Geography: United States (label of the US Food and Drug Administration); Life stage: Not stated in the label passages read; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (label statement)
- Limitations: This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked: 2026-11-09
- Sources:
  1. Supports: openFDA drug label record for verapamil hydrochloride tablets, Actavis Pharma, Inc. label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id a0343397-897b-46d6-943f-a87e07e1de10 (manufacturer Actavis Pharma, Inc., application ANDA070995), returned on 2026-11-09. The label text is dated 2024-01-30 (effective\_time). Other openFDA records of verapamil labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22a0343397-897b-46d6-943f-a87e07e1de10%22&limit=1>
     Locator: results\[0\].indications\_and\_usage\[0\]. Retrieved 2026-11-09T13:17:49Z. Source state: Current. Version fingerprint: c29bed22ccec22e108dfe8ae23e8b2c021c7d8c27c14deb0f1c2bf7da2406a35.
     How it applies: The label sentences that give the indications named in the statement, each quoted in the research quote table.
  2. Background: openFDA drug label record for verapamil hydrochloride tablets, Actavis Pharma, Inc. label: indications and substance identifiers (Regulator, edition The openFDA drug label record for set id a0343397-897b-46d6-943f-a87e07e1de10 (manufacturer Actavis Pharma, Inc., application ANDA070995), returned on 2026-11-09. The label text is dated 2024-01-30 (effective\_time). Other openFDA records of verapamil labels from other sponsors and repackagers exist and were not used.) <https://api.fda.gov/drug/label.json?search=set_id:%22a0343397-897b-46d6-943f-a87e07e1de10%22&limit=1>
     Locator: results\[0\].effective\_time. Retrieved 2026-11-09T13:17:49Z. Source state: Current. Version fingerprint: c29bed22ccec22e108dfe8ae23e8b2c021c7d8c27c14deb0f1c2bf7da2406a35.
     How it applies: Effective date of the label text read, 20240130.

## Connected pages

- Verapamil is a calcium channel blocker (FDA established pharmacologic class in RxClass): Calcium channel blockers (`cardio:calcium-channel-blockers`)
- FDA label lists hypertension as an indication: Hypertension (high blood pressure) (`core:hypertension`) [a claim, not a settled fact; see claim `cardio:claim-fda-verapamil-label-indications` and its context]
- FDA label lists chronic stable angina as an indication: Stable angina (`cardio:stable-angina`) [a claim, not a settled fact; see claim `cardio:claim-fda-verapamil-label-indications` and its context]
- FDA label lists angina at rest, including unstable (crescendo, pre-infarction) angina, as an indication: Unstable angina (`cardio:unstable-angina`) [a claim, not a settled fact; see claim `cardio:claim-fda-verapamil-label-indications` and its context]
- FDA label lists ventricular rate control, in association with digitalis, in chronic atrial flutter or atrial fibrillation as an indication: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`) [a claim, not a settled fact; see claim `cardio:claim-fda-verapamil-label-indications` and its context]
- FDA label lists ventricular rate control, in association with digitalis, in chronic atrial flutter or atrial fibrillation as an indication: Atrial flutter (`cardio:atrial-flutter`) [a claim, not a settled fact; see claim `cardio:claim-fda-verapamil-label-indications` and its context]
- FDA label lists prophylaxis of repetitive paroxysmal supraventricular tachycardia as an indication: Supraventricular tachycardia (`cardio:supraventricular-tachycardia`) [a claim, not a settled fact; see claim `cardio:claim-fda-verapamil-label-indications` and its context]
- Files under this front: Medicines (`cardio:front-medicines`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 10 registry products
- 3 registry trials

## Provenance

Content hash: eabbf4dbac6a8c1ccf83fe9587ddc65a286941674d18cc961ef475e783500fe7
Last substantive edit: 2026-11-09
Evidence last checked: 2026-11-09
